Tau PET and tauopathies

被引：4
作者：
Herholz, Karl [1 ]
机构：
[1] Univ Manchester, Inst Brain Behav & Mental Hlth, Wolfson Mol Imaging Ctr, 27 Palatine Rd, Manchester M20 3LJ, Lancs, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷 / 09期
关键词：
ALZHEIMERS-DISEASE;
D O I：
10.1007/s00259-016-3406-5
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1684 / 1685
页数：2
相关论文
共 12 条
  • [1] CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease
    Ceravolo, R.
    Borghetti, D.
    Kiferle, L.
    Tognoni, G.
    Giorgetti, A.
    Neglia, D.
    Sassi, N.
    Frosini, D.
    Rossi, C.
    Petrozzi, L.
    Siciliano, G.
    Murri, L.
    [J]. BRAIN RESEARCH BULLETIN, 2008, 76 (1-2) : 80 - 84
  • [2] Tau imaging in neurodegenerative diseases
    Dani, M.
    Brooks, D. J.
    Edison, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (06) : 1139 - 1150
  • [3] 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
    Harada, Ryuichi
    Okamura, Nobuyuki
    Furumoto, Shozo
    Furukawa, Katsutoshi
    Ishiki, Aiko
    Tomita, Naoki
    Tago, Tetsuro
    Hiraoka, Kotaro
    Watanuki, Shoichi
    Shidahara, Miho
    Miyake, Masayasu
    Ishikawa, Yoichi
    Matsuda, Rin
    Inami, Akie
    Yoshikawa, Takeo
    Funaki, Yoshihito
    Iwata, Ren
    Tashiro, Manabu
    Yanai, Kazuhiko
    Arai, Hiroyuki
    Kudo, Yukitsuka
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (02) : 208 - 214
  • [4] Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment
    Herholz, Karl
    Westwood, Sarah
    Haense, Cathleen
    Dunn, Graham
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (08) : 1218 - 1226
  • [5] Identifying and validating biomarkers for Alzheimer's disease
    Humpel, Christian
    [J]. TRENDS IN BIOTECHNOLOGY, 2011, 29 (01) : 26 - 32
  • [6] PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
    Jellinger, Kurt A.
    Alafuzoff, Irina
    Attems, Johannes
    Beach, Thomas G.
    Cairns, Nigel J.
    Crary, John F.
    Dickson, Dennis W.
    Hof, Patrick R.
    Hyman, Bradley T.
    Jack, Clifford R., Jr.
    Jicha, Gregory A.
    Knopman, David S.
    Kovacs, Gabor G.
    Mackenzie, Ian R.
    Masliah, Eliezer
    Montine, Thomas J.
    Nelson, Peter T.
    Schmitt, Frederick
    Schneider, Julie A.
    Serrano-Pozo, Albert
    Thal, Dietmar R.
    Toledo, Jonathan B.
    Trojanowski, John Q.
    Troncoso, Juan C.
    Vonsattel, Jean Paul
    Wisniewski, Thomas
    [J]. ACTA NEUROPATHOLOGICA, 2015, 129 (05) : 757 - 762
  • [7] Joshi AD, 2012, J NUCL MED, V53, P378, DOI 10.2967/jnumed.111.090340
  • [8] Rabinovici G, 2015, NEUROL S, V84
  • [9] PET Imaging of Tau Deposition in the Aging Human Brain
    Schoell, Michael
    Lockhart, Samuel N.
    Schonhaut, Daniel R.
    O'Neil, James P.
    Janabi, Mustafa
    Ossenkoppele, Rik
    Baker, Suzanne L.
    Vogel, Jacob W.
    Faria, Jamie
    Schwimmer, Henry D.
    Rabinovici, Gil D.
    Jagust, William J.
    [J]. NEURON, 2016, 89 (05) : 971 - 982
  • [10] Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages
    Schwarz, Adam J.
    Yu, Peng
    Miller, Bradley B.
    Shcherbinin, Sergey
    Dickson, James
    Navitsky, Michael
    Joshi, Abhinay D.
    Devous, Michael D.
    Mintun, Mark S.
    [J]. BRAIN, 2016, 139 : 1539 - 1550
12